風語築(603466.SH):勵構投資及程曉霞擬減持合計不超1.99%股份
格隆匯11月13日丨風語築(603466.SH)公佈,截至本公告披露日,上海勵構投資合夥企業(有限合夥)(以下簡稱“勵構投資”)持有公司股份2000萬股,約佔公司總股本的6.86%,勵構投資系公司上市前員工的持股平台。程曉霞持有公司股份90萬股,約佔公司總股本的0.31%。
自本公告披露之日起15個交易日後的6個月內,勵構投資通過集中競價交易或大宗交易方式減持股份數量不超過489萬股,即不超過公司總股本的1.68%。程曉霞通過集中競價交易或大宗交易方式減持股份數量不超過90萬股,即不超過公司總股本的0.31%。具體減持價格根據減持實施時的市場價格確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.